CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2.
about
CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
CYP17A1 inhibitor abiraterone, ...... droxylase activity of CYP21A2.
@en
CYP17A1 inhibitor abiraterone, ...... droxylase activity of CYP21A2.
@nl
type
label
CYP17A1 inhibitor abiraterone, ...... droxylase activity of CYP21A2.
@en
CYP17A1 inhibitor abiraterone, ...... droxylase activity of CYP21A2.
@nl
prefLabel
CYP17A1 inhibitor abiraterone, ...... droxylase activity of CYP21A2.
@en
CYP17A1 inhibitor abiraterone, ...... droxylase activity of CYP21A2.
@nl
P2093
P50
P1476
CYP17A1 inhibitor abiraterone, ...... droxylase activity of CYP21A2.
@en
P2093
Bernhard Dick
Jana Malikova
Rita Bernhardt
Shaheena Parween
P304
P356
10.1016/J.JSBMB.2017.09.007
P577
2017-09-08T00:00:00Z